Dimosthenis Andreas Sarigiannis

Prof. Dr. Dimosthenis Andreas Sarigiannis


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Environment International
Verified
Journal Article
Closed access
Dimosthenis SarigiannisDimosthenis Sarigiannis
Dimosthenis Sarigiannis
SKSpyros P. Karakitsios
Spyros P. Karakitsios
AGAlberto Gotti
Alberto Gotti
Ioannis LiakosIoannis Liakos
Ioannis Liakos
AKAthanasios Katsoyiannis
Athanasios Katsoyiannis

14 June 2017 in BMJ Open
Verified
Journal Article
Open access
PDF file
JGJames Grellier
James Grellier
MWMathew P White
Mathew P White
MAMaria Albin
Maria Albin
Simon BellSimon Bell
Simon Bell
LELewis Elliott
Lewis Elliott
LFLora E Fleming
Lora E Fleming
Introduction Proximity and access to water have long been central to human culture and accordingly deliver countless societal benefits. Over 200 million people live on Europe's coastline, and aquatic environments are the top recreational destination in the region. In terms of public health, interactions with ‘blue space’ (eg, coasts, rivers, lakes) are often considered solely in terms of risk (eg, drowning, microbial pollution). Exposure to blue space can, however, promote health and well-being and prevent disease, although underlying mechanisms are poorly understood. Aims and methods The BlueHealth project aims to understand the relationships between exposure to blue space and health and well-being, to map and quantify the public health impacts of changes to both natural blue spaces and associated urban infrastructure in Europe, and to provide evidence-based information to policymakers on how to maximise health benefits associated with interventions in and around aquatic environments. To achieve these aims, an evidence base will be created through systematic reviews, analyses of secondary data sets and analyses of new data collected through a bespoke international survey and a wide range of community-level interventions. We will also explore how to deliver the benefits associated with blue spaces to those without direct access through the use of virtual reality. Scenarios will be developed that allow the evaluation of health impacts in plausible future societal contexts and changing environments. BlueHealth will develop key inputs into policymaking and land/water-use planning towards more salutogenic and sustainable uses of blue space, particularly in urban areas. Ethics and dissemination Throughout the BlueHealth project, ethics review and approval are obtained for all relevant aspects of the study by the local ethics committees prior to any work being initiated and an ethics expert has been appointed to the project advisory board. So far, ethical approval has been obtained for the BlueHealth International Survey and for community-level interventions taking place in Spain, Italy and the UK. Engagement of stakeholders, including the public, involves citizens in many aspects of the project. Results of all individual studies within the BlueHealth project will be published with open access. After full anonymisation and application of any measures necessary to prevent disclosure, data generated in the project will be deposited into open data repositories of the partner institutions, in line with a formal data management plan. Other knowledge and tools developed in the project will be made available via the project website (www.bluehealth2020.eu). Project results will ultimately provide key inputs to planning and policy relating to blue space, further stimulating the integration of environmental and health considerations into decision-making, such that blue infrastructure is developed across Europe with both public health and the environment in mind.

1 March 2017 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Closed access
CGCatherine Ganzleben
Catherine Ganzleben
JAJean-Philippe Antignac
Jean-Philippe Antignac
RBRobert Barouki
Robert Barouki
ACArgelia Castaño
Argelia Castaño
UFUlrike Fiddicke
Ulrike Fiddicke
MKMarike Kolossa-Gehring
Marike Kolossa-Gehring

1 February 2015 in Environmental Research
Verified
Journal Article
Closed access
Dimosthenis SarigiannisDimosthenis Sarigiannis
Dimosthenis Sarigiannis
SKSpyros P. Karakitsios
Spyros P. Karakitsios
DZDimitrios Zikopoulos
Dimitrios Zikopoulos
SNSpyridoula Nikolaki
Spyridoula Nikolaki
MKMarianthi Kermenidou
Marianthi Kermenidou

1 January 2012 in Environmental Health
Verified
Journal Article
Open access
PDF file
Dimosthenis SarigiannisDimosthenis Sarigiannis
Dimosthenis Sarigiannis
UHUte Hansen
Ute Hansen
The current paradigm for the assessment of the health risk of chemical substances focuses primarily on the effects of individual substances for determining the doses of toxicological concern in order to inform appropriately the regulatory process. These policy instruments place varying requirements on health and safety data of chemicals in the environment. REACH focuses on safety of individual substances; yet all the other facets of public health policy that relate to chemical stressors put emphasis on the effects of combined exposure to mixtures of chemical and physical agents. This emphasis brings about methodological problems linked to the complexity of the respective exposure pathways; the effect (more complex than simple additivity) of mixtures (the so-called 'cocktail effect'); dose extrapolation, i.e. the extrapolation of the validity of dose-response data to dose ranges that extend beyond the levels used for the derivation of the original dose-response relationship; the integrated use of toxicity data across species (including human clinical, epidemiological and biomonitoring data); and variation in inter-individual susceptibility associated with both genetic and environmental factors. In this paper we give an overview of the main methodologies available today to estimate the human health risk of environmental chemical mixtures, ranging from dose addition to independent action, and from ignoring interactions among the mixture constituents to modelling their biological fate taking into account the biochemical interactions affecting both internal exposure and the toxic potency of the mixture. We discuss their applicability, possible options available to policy makers and the difficulties and potential pitfalls in implementing these methodologies in the frame of the currently existing policy framework in the European Union. Finally, we suggest a pragmatic solution for policy/regulatory action that would facilitate the evaluation of the health effects of chemical mixtures in the environment and consumer products. One universally applicable methodology does not yet exist. Therefore, a pragmatic, tiered approach to regulatory risk assessment of chemical mixtures is suggested, encompassing (a) the use of dose addition to calculate a hazard index that takes into account interactions among mixture components; and (b) the use of the connectivity approach in data-rich situations to integrate mechanistic knowledge at different scales of biological organization.

1 January 2019 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
IKIoanna Katsikantami
Ioanna Katsikantami
CCClaudio Colosio
Claudio Colosio
AAAthanasios Alegakis
Athanasios Alegakis
MTManolis N. Tzatzarakis
Manolis N. Tzatzarakis
EVElena Vakonaki
Elena Vakonaki
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis